InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Zalevsky Jonathan. Officer active across 1 company, notably NEKTAR THERAPEUTICS. Cumulatively, 1 reports have been recorded. Activity tracked since 18 August 2026. The latest transaction was filed on 18 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.